Revance Therapeutics, Inc.
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect

Abstract:

The invention provides methods for treating primary disorders of mood and affect, including depressive disorders, anxiety and sleep disorders and CNS disorders comprising the administration of a neurotoxin.